We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation

Delisted

AGTC was delisted on the 30th of November, 2022.

88 hedge funds and large institutions have $223M invested in Applied Genetic Technologies Corporation in 2015 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 31 increasing their positions, 12 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 4

158% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 12

84% more capital invested

Capital invested by funds: $121M → $223M (+$102M)

47% more funds holding

Funds holding: 6088 (+28)

Holders
88
Holders Change
+28
Holders Change %
+46.67%
% of All Funds
2.31%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.08%
New
32
Increased
31
Reduced
12
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$35.9M +$6.28M +407,334 +30%
PA
2
Perceptive Advisors
New York
$17.6M +$162K +10,521 +1%
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$14.7M -$4.33M -280,900 -28%
Jennison Associates
4
Jennison Associates
New York
$13.8M +$50.1K +3,248 +0.5%
VAM
5
Visium Asset Management
New York
$9.69M -$7.25M -469,700 -50%
BFA
6
BlackRock Fund Advisors
California
$9.11M +$3.39M +219,502 +97%
PI
7
Putnam Investments
Massachusetts
$8.44M +$266K +17,228 +4%
Vanguard Group
8
Vanguard Group
Pennsylvania
$7.28M +$1.2M +77,946 +28%
TC
9
TFS Capital
Pennsylvania
$5.97M +$3.6M +233,442 +394%
EAM
10
EverPoint Asset Management
Connecticut
$5.96M -$4.36M -282,800 -49%
EAM
11
Eventide Asset Management
Massachusetts
$5.69M +$441K +28,600 +11%
RCI
12
Ridgeback Capital Investments
Florida
$5.02M +$3.79M +246,005 New
RCM
13
RA Capital Management
Massachusetts
$4.82M +$1.77M +114,959 +95%
NI
14
Numeric Investors
Massachusetts
$4.62M +$3.17M +205,789 +985%
EMFAT
15
Emerald Mutual Fund Advisers Trust
Pennsylvania
$4.19M +$3.17M +205,401 New
AGA
16
Altrinsic Global Advisors
Connecticut
$4.06M +$463K +30,000 +18%
T. Rowe Price Associates
17
T. Rowe Price Associates
Maryland
$3.88M
EA
18
Emerald Advisers
Pennsylvania
$3.77M +$2.85M +184,610 New
Millennium Management
19
Millennium Management
New York
$3.74M -$2.55M -165,282 -47%
JP Morgan Chase
20
JP Morgan Chase
New York
$3.56M -$381K -24,688 -12%
DCM
21
DAFNA Capital Management
California
$3.21M
IHM
22
Iguana Healthcare Management
New York
$3.06M +$386K +25,000 +20%
BIT
23
BlackRock Institutional Trust
California
$2.91M +$345K +22,346 +19%
BIM
24
Bogle Investment Management
Massachusetts
$2.67M +$2.02M +130,926 New
PAM
25
Panagora Asset Management
Massachusetts
$2.63M +$717K +46,449 +56%

AGTC Hedge Fund Activity: Q4 2015 in Review

88 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q4 2015, worth a combined $223M — up 84% from $121M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new AGTC positions and 4 closed out — a net gain of 28 holders — while 31 added to existing stakes and 12 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $6.28M. The largest seller was Visium Asset Management, cutting an estimated $7.25M.

  • 88 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q4 2015, up from 60 in Q3 2015.
  • Funds reported $223M of Applied Genetic Technologies Corporation stock for Q4 2015, up 84% quarter-over-quarter.
  • 32 funds opened new Applied Genetic Technologies Corporation positions in Q4 2015 and 4 closed out, a net change of +28 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q4 2015 was Fidelity Investments, an estimated $6.28M added.
  • The largest Applied Genetic Technologies Corporation seller in Q4 2015 was Visium Asset Management, an estimated $7.25M sold.

Based on aggregated 13F filings for Q4 2015.